Research letterMicromelanomas identified with time-lapse total body photography and dermoscopy
References (5)
- et al.
Cutaneous melanoma in situ: translational evidence from a large population-based study
Oncologist
(2011) - et al.
Comparative analysis of total body and dermatoscopic photographic monitoring of nevi in similar patient populations at risk for cutaneous melanoma
Dermatol Surg
(2010)
There are more references available in the full text version of this article.
Cited by (17)
Skin cancer screening using total body photography and digital dermoscopy: A pilot study among Florida firefighters
2022, Journal of the American Academy of DermatologySmall-diameter melanomas (micromelanomas): clinical, dermoscopic and histopathological findings
2022, Anais Brasileiros de DermatologiaDermoscopy features of melanomas with a diameter up to 5 mm (micromelanomas): A retrospective study
2020, Journal of the American Academy of DermatologyCorrelation of total body photography frequency and invasive melanoma depth
2020, Journal of the American Academy of DermatologyMelanoma diagnosis at a specialist dermatology practice without the use of photographic surveillance
2023, Australasian Journal of Dermatology
Funding sources: None.
Rhett Drugge, MD, is the inventor and holder of the intellectual property rights (US patent 7,359,748) of the Melanoscan system. E. Drugge is a first-degree relative of Dr Drugge. The other authors have no conflicts of interest to declare.
We thank George F. Murphy, MD, Director of Dermatopathology at BWH Consulting.
© 2017 by the American Academy of Dermatology, Inc.